serial	Pathway	Set Size	Percent Up	NTk Stat	NTk q-value	NTk Rank	NEk Stat	NEk q-value	NEk Rank
1	NF-kappa B signaling pathway	60	83.3	-7.55	0	1	-3.09	0.0923	2
2	Measles	74	75.7	-6.47	0	3	-3.09	0.0923	2
3	Osteoclast differentiation	95	79	-7.54	0	2	-2.51	0.208	7.5
4	Influenza A	81	72.8	-5.43	0	6	-2.88	0.138	4
5	Legionellosis	31	77.4	-4.98	0	7	-2.65	0.222	5
6	Apoptosis	71	74.7	-4.82	0	10	-3.09	0.0923	2
7	Natural killer cell mediated cytotoxicity	78	66.7	-5.83	0	5	-2.46	0.194	9.5
8	Hepatitis B	97	68	-4.82	0	9	-2.51	0.208	7.5
9	Amoebiasis	36	80.6	-4.24	0	13	-2.58	0.231	6
10	Toll-like receptor signaling pathway	71	73.2	-4.95	0	8	-2.14	0.261	16
11	Rheumatoid arthritis	15	80	-3.86	0	15	-2.26	0.302	11
12	Herpes simplex infection	59	71.2	-4.22	0	14	-2.17	0.297	13.5
13	HIF-1 signaling pathway	87	64.4	-3.16	0	21	-2.46	0.194	9.5
14	Cytosolic DNA-sensing pathway	18	77.8	-3.37	0	20	-2.2	0.323	12
15	T cell receptor signaling pathway	77	64.9	-3.53	0	18	-2.14	0.261	16
16	Antigen processing and presentation	36	91.7	-6.45	0	4	-1.83	0.285	32.5
17	Chagas disease (American trypanosomiasis)	71	69	-3.52	0	19	-2.12	0.248	18.5
18	Intestinal immune network for IgA production	18	88.9	-4.55	0	12	-1.94	0.267	26
19	B cell receptor signaling pathway	57	68.4	-3.62	0	17	-1.96	0.288	24
20	Toxoplasmosis	74	71.6	-3.09	0.0075	23.5	-2.12	0.248	18.5
21	Malaria	8	75	-3.09	0.0075	23.5	-2.1	0.249	20
22	Epstein-Barr virus infection	67	62.7	-2.75	0.0187	30	-2.17	0.297	13.5
23	Viral myocarditis	20	75	-2.88	0.0129	28	-2.14	0.261	16
24	Jak-STAT signaling pathway	81	67.9	-3.09	0.0075	23.5	-2	0.277	22.5
25	Leishmaniasis	37	75.7	-3.75	0	16	-1.81	0.277	34.5
26	Amino sugar and nucleotide sugar metabolism	38	81.6	-2.88	0.0129	28	-2	0.277	22.5
27	Hepatitis C	66	65.2	-3.09	0.0075	23.5	-1.9	0.268	29.5
28	Salmonella infection	46	73.9	-2.65	0.0227	32.5	-1.94	0.267	26
29	African trypanosomiasis	13	76.9	-2.26	0.0577	38	-2.05	0.264	21
30	Cell adhesion molecules (CAMs)	64	68.8	-4.67	0	11	-1.47	0.364	54
31	Selenocompound metabolism	8	37.5	2.23	0.0595	40.5	1.94	0.267	26
32	NOD-like receptor signaling pathway	31	64.5	-2.26	0.0577	38	-1.9	0.268	29.5
33	Pertussis	41	70.7	-2.65	0.0227	32.5	-1.72	0.29	40.5
34	Serotonergic synapse	60	70	-2.26	0.0577	38	-1.79	0.285	36
35	Cholinergic synapse	70	68.6	-1.96	0.0997	47	-1.91	0.277	28
36	RIG-I-like receptor signaling pathway	33	69.7	-2.51	0.0331	34	-1.59	0.31	49.5
37	Long-term depression	45	71.1	-2.12	0.0759	42	-1.64	0.321	44
38	Dorso-ventral axis formation	10	70	-1.67	0.155	56	-1.84	0.295	31
39	Fat digestion and absorption	8	12.5	2.23	0.0595	40.5	1.61	0.318	47
40	Transcriptional misregulation in cancer	15	80	-1.67	0.155	56	-1.83	0.285	32.5
41	Graft-versus-host disease	8	100	-2.92	0.00721	26	-1.39	0.348	65.5
42	Steroid hormone biosynthesis	25	68	-1.74	0.145	53	-1.73	0.298	39
43	Leukocyte transendothelial migration	66	69.7	-2.88	0.0129	28	-1.39	0.348	65.5
44	Retinol metabolism	26	65.4	-1.91	0.109	48	-1.63	0.313	45.5
45	Amyotrophic lateral sclerosis (ALS)	32	68.8	-1.77	0.14	51	-1.65	0.316	43
46	p53 signaling pathway	50	66	-2.01	0.0917	45	-1.59	0.31	49.5
47	Long-term potentiation	55	61.8	-1.58	0.184	58	-1.77	0.284	37
48	Citrate cycle (TCA cycle)	23	43.5	2.75	0.0181	31	1.36	0.349	68
49	Glutamatergic synapse	67	70.2	-2.07	0.0828	43	-1.45	0.36	57
50	Vibrio cholerae infection	14	71.4	-1.33	0.247	69	-1.81	0.277	34.5